PREVENTION OF CARDIAC DISEASE BY SUBCUTANEOUS DEFEROXAMINE IN PATIENTS WITH THALASSEMIA MAJOR

被引：255
|
作者：
WOLFE, L
OLIVIERI, N
SALLAN, D
COLAN, S
ROSE, V
PROPPER, R
FREEDMAN, MH
NATHAN, DG
机构：
[1] CHILDRENS HOSP MED CTR, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA
[2] DANA FARBER CANC INST, BOSTON, MA USA
[3] HOSP SICK CHILDREN, DIV HEMATOL, TORONTO M5G 1X8, ONTARIO, CANADA
[4] HOSP SICK CHILDREN, DEPT CARDIOL, TORONTO M5G 1X8, ONTARIO, CANADA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1985年 / 312卷 / 25期
关键词：
D O I：
10.1056/NEJM198506203122503
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1600 / 1603
页数：4
相关论文
共 50 条
  • [41] SPINAL DEFORMITIES IN DEFEROXAMINE-TREATED HOMOZYGOUS BETA-THALASSEMIA MAJOR PATIENTS
    HARTKAMP, MJ
    BABYN, PS
    OLIVIERI, F
    PEDIATRIC RADIOLOGY, 1993, 23 (07) : 525 - 528
  • [42] Deferiprone or deferoxamine vs Combination therapyin patients with β-thalassemia major:: A case study in Taiwan
    Peng, CT
    Wu, KH
    Wu, SF
    Liang, DC
    Yang, CP
    Jang, RC
    Wang, LY
    Hsiao, CC
    HEMOGLOBIN, 2006, 30 (01) : 125 - 130
  • [43] Effects of combined therapy with deferiprone and deferoxamine on gonadal function in male patients with β-thalassemia major
    Farmaki, K.
    Angelopoulos, N.
    Pappa, C.
    Anagnostopoulos, G.
    Tzoumari, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 479 - 479
  • [44] Combination of deferasirox and deferoxamine in clinical practice: An alternative scheme of chelation in thalassemia major patients
    Cassinerio, E.
    Orofino, N.
    Roghi, A.
    Duca, L.
    Poggiali, E.
    Fraquelli, M.
    Zanaboni, L.
    Cappellini, M. D.
    BLOOD CELLS MOLECULES AND DISEASES, 2014, 53 (03) : 164 - 167
  • [45] COMBINED SUBCUTANEOUS AND HIGH-DOSE INTRAVENOUS DEFEROXAMINE THERAPY OF THALASSEMIA
    HYMAN, CB
    AGNESS, CL
    RODRIGUEZFUNES, R
    ZEDNIKOVA, M
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 445 (JUN) : 293 - 303
  • [46] Dose-dependent pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine
    Rego, EM
    Neto, EB
    Simoes, BP
    Zago, MA
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 58 (04) : 340 - 341
  • [47] Combination therapy - deferasirox and deferoxamine - in thalassemia major patients in emerging countries with limited resources
    Arandi, N.
    Haghpanah, S.
    Safaei, S.
    Zahedi, Z.
    Ashrafi, A.
    Eatemadfar, P.
    Zarei, T.
    Radwan, A. H.
    Taher, A. T.
    Karimi, M.
    TRANSFUSION MEDICINE, 2015, 25 (01) : 8 - 12
  • [48] COMBINATION OF DEFERASIROX AND DEFEROXAMINE A SUCCESSFUL CHELATION THERAPY IN B-THALASSEMIA MAJOR PATIENTS
    Petropoulou, F.
    Ventiadi, K.
    Leveta, G.
    HAEMATOLOGICA, 2017, 102 : 868 - 868
  • [49] Cardiac magnetic resonance characterization of Thalassemia Intermedia patients confronted with Thalassemia Major patients
    Pepe, A
    Cracolici, E
    Santarelli, MF
    Aquaro, G
    De Marchi, D
    Deiana, M
    Di Salvo, V
    Borsellino, Z
    Pitrolo, L
    Midiri, M
    Lombardi, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 136A - 136A
  • [50] RELATIONSHIP BETWEEN NEUROTOXICITY AND PHARMACOKINETICS OF DEFEROXAMINE IN CHILDREN WITH THALASSEMIA MAJOR
    BENTUR, Y
    KOREN, G
    TESORO, A
    FREEDMAN, M
    PEDIATRIC RESEARCH, 1989, 25 (04) : A64 - A64
12345